{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CDK1/2", "Emodin-8-O-\u03b2-D-glucopyranoside", "Rb phosphorylation", "Tumor growth inhibition", "p21"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35134436", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1016/j.taap.2022.115909", "S0041-008X(22)00054-0"], "Journal": {"ISSN": "1096-0333", "JournalIssue": {"Volume": "438", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "01"}}, "Title": "Toxicology and applied pharmacology", "ISOAbbreviation": "Toxicol Appl Pharmacol"}, "ArticleTitle": "Emodin-8-O-\u03b2-D-glucopyranoside, a natural hydroxyanthraquinone glycoside from plant, suppresses cancer cell proliferation via p21-CDKs-Rb axis.", "Pagination": {"StartPage": "115909", "MedlinePgn": "115909"}, "Abstract": {"AbstractText": ["Emodin-8-O-\u03b2-D-glucopyranoside (EG), a natural hydroxyanthraquinone glycoside from some traditional medicinal plants, has been demonstrated to have potential antitumor effects in our previous studies. Herein, we confirm that EG remains stable in the cell culture medium. It suppresses cell viability and proliferation and induces G1 cell cycle arrest in human colorectal cancer and neuroblastoma cells in vitro. EG inhibits tumor growth in human colorectal cancer cell HCT 116-bearing xenograft mice with low toxicity in the liver and kidney. The transcriptome analysis shows that the p53 signaling pathway is the most enriched cellular pathway and EG affects the proliferation of HCT 116 cells through modulating cell cycle related genes, such as CDKN1A and Cyclin-dependent kinases (CDKs). We demonstrate that the protein expression level of p21 was up-regulated, and CDK1/CDK2 were reduced significantly in both HCT 116 and SH-SY5Y cells after EG treatment. The switch from hypo- to hyper-phosphorylated Retinoblastoma (Rb), which is believed as a result of activated CDKs, was inhibited when cells were treated with EG. These findings indicate that EG suppresses cancer cell proliferation via p21-CDKs-Rb axis."], "CopyrightInformation": "Copyright \u00a9 2022. Published by Elsevier Inc."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Li", "ForeName": "Yiqun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Li", "ForeName": "Kaiming", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Zhao", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Li", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Li", "ForeName": "Dengke", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Shen", "ForeName": "Liangliang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA."}], "LastName": "Wang", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, USA. Electronic address: hyang3@uky.edu."}], "LastName": "Yang", "ForeName": "Hsin-Sheng", "Initials": "HS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Electronic address: sunzxcn@hotmail.com."}], "LastName": "Sun", "ForeName": "Zhenxiao", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Toxicol Appl Pharmacol", "NlmUniqueID": "0416575", "ISSNLinking": "0041-008X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anthraquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "CDKN1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclin-Dependent Kinase Inhibitor p21"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Retinoblastoma Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinases"}, {"RegistryNumber": "KA46RNI6HN", "NameOfSubstance": "Emodin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anthraquinones"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclin-Dependent Kinase Inhibitor p21"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclin-Dependent Kinases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Emodin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "HT29 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["drug effects"], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Retinoblastoma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Retinoblastoma Protein"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Suppressor Protein p53"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "9", "Day": "8"}, {"Year": "2022", "Month": "1", "Day": "26"}, {"Year": "2022", "Month": "2", "Day": "1"}, {"Year": "2022", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "8", "Hour": "20", "Minute": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35134436", "10.1016/j.taap.2022.115909", "S0041-008X(22)00054-0"]}}], "PubmedBookArticle": []}